“…Dihydropyrimidin‐2(1H)‐ones/thiones displayed variety of biological activity [5–7] . Hence, several homogeneous catalysts especially Lewis acids such as BiCl 3 , Bi(OTf) 3 , Bi(NO 3 ) 3 , CeCl 3 7H 2 O, Cu(OTf) 2 , CuCl 2 2H 2 O/CuSO 4 5H 2 O, Fe(NO 3 ) 3 9H 2 O, Fe(OTs) 3 6H 2 O, GaCl 3 , Hf(OTf) 4, In(OTf) 3 , RuCl 3 , SbCl 3 , SnCl 2 2H 2 O, Sr(OTf) 2 , TiCl 4 , Yb(OTf) 3 , ZnCl 2 , ZrCl 4 and ZrCl 4 or ZrOCl 2 8H 2 O [8–27] subsequently were developed to enhance the yield of product. All mentioned catalysts improved the yield of product but most of them are expensive; difficult to remove from solution consequently metal traces can be remained in the final product and reusability are the key issues.…”